MedPath

First Affiliated Hospital of Wenzhou Medical University

People's Republic of China
Ownership
Private
Established
1956-01-01
Employees
-
Market Cap
-
Website
http://www.dyyy.xjtu.edu.cn/

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

Not Applicable
Not yet recruiting
Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
Biological: Cell injection
First Posted Date
2025-03-21
Last Posted Date
2025-03-21
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
35
Registration Number
NCT06888752

Positive Psychological Intervention for Parkinson's Disease Patients

Not Applicable
Completed
Conditions
Parkinson
First Posted Date
2025-02-18
Last Posted Date
2025-02-18
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
60
Registration Number
NCT06832358
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Not Applicable
Not yet recruiting
Conditions
Myasthenia Gravis
Autoimmune Diseases
Neuromuscular Diseases
Interventions
Drug: Efgartigimod + Telitacicept (1-week interval) group
Drug: Efgartigimod + Telitacicept (2-week interval) group
Drug: Telitacicept-only group
First Posted Date
2025-02-14
Last Posted Date
2025-02-14
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
60
Registration Number
NCT06827587

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

Phase 4
Not yet recruiting
Conditions
Myasthenia Gravis
Autoimmune Diseases
Interventions
First Posted Date
2024-12-09
Last Posted Date
2024-12-09
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
30
Registration Number
NCT06723548

Study on Aging and Cognitive Impairment in China

Recruiting
Conditions
Cognitive Dysfunction
Aging
First Posted Date
2024-11-07
Last Posted Date
2024-11-07
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
20000
Registration Number
NCT06679296
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

Phase 2
Not yet recruiting
Conditions
Nausea and Vomiting, Chemotherapy-Induced
Interventions
First Posted Date
2024-09-13
Last Posted Date
2024-09-19
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
180
Registration Number
NCT06593782

Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

Phase 2
Recruiting
Conditions
Drug Therapy
Metastatic Colorectal Cancer
Interventions
Drug: trifluridine/tipiracil combined with fufuquitinib
Drug: fufuquitinib
First Posted Date
2024-07-03
Last Posted Date
2024-07-03
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
200
Registration Number
NCT06485713
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer

Early Phase 1
Not yet recruiting
Conditions
Advanced Gastric Cancer
Interventions
Biological: Neoantigen Reactive T Cells(NRTs)
First Posted Date
2024-05-29
Last Posted Date
2024-05-29
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
20
Registration Number
NCT06432075

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

Early Phase 1
Not yet recruiting
Conditions
Sjogren's Syndrome
Antiphospholipid Syndrome
Systemic Lupus Erythematosus (SLE)
Systemic Sclerosis
Inflammatory Myopathy
ANCA Associated Vasculitis
Interventions
Biological: anti-CD19-CAR-T cells
First Posted Date
2024-05-17
Last Posted Date
2024-05-17
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
9
Registration Number
NCT06420154
Locations
🇨🇳

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Dual-port Trans-subclavian Thyroid Endoscopic Surgery

Not Applicable
Recruiting
Conditions
Endoscopic Surgery
Thyroid Neoplasms
Interventions
Procedure: Dual-port Trans-subclavian Thyroid Endoscopic Surgery (DTS).
Procedure: Conventional open thyroidectomy (COT)
First Posted Date
2024-05-03
Last Posted Date
2024-12-31
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
300
Registration Number
NCT06398795
Locations
🇨🇳

First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath